Biotech · Private company
Aviceda Therapeutics, Inc.
Track this companyFree. Adds Aviceda Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- AvacincaptadPhase 2 · Geographic Atrophy of the MaculaClinicalTrials.gov · fetched Nov 12, 2026
- AVD-104Phase 2 · Diabetic Macular EdemaClinicalTrials.gov · fetched Nov 12, 2026
- AVD-104Phase 2 · Geographic Atrophy of the MaculaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- A Phase 2 Study of Intravitreal AVD-104 in Diabetic Macular EdemaPHASE2 · TERMINATED · started Nov 30, 2023ClinicalTrials.gov NCT06181227 · fetched Nov 12, 2026
- A Multiple Dose Study of AVD-104 for Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)PHASE2 · COMPLETED · started May 2, 2023ClinicalTrials.gov NCT05839041 · fetched Nov 12, 2026